LINC02691

Across TCGA pan-cancer cohorts, LINC02691 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02691 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02691 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02691 expression acts as an unfavorable survival marker, although some lineages such as UCS and LIHC show a favorable association.

BLCA, SKCM, and LUSC are the cancer types where LINC02691 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.424	0.569	<.001	142	view →
SKCM	OS	Median	All	0.259	0.394	<.001	94	view →
LUSC	DFS	Quartile	II,III,IV	0.408	0.709	<.001	80	view →
UCS	OS	Median	III,IV	0.750	0.399	.003	66	view →
CESC	DFS	Quartile	III,IV	0.240	0.683	<.001	36	view →
LIHC	OS	Median	III,IV	0.770	0.470	.006	25	view →
COAD	OS	Quartile	All	0.769	0.900	.019	21	view →
LUAD	OS	Median	All	0.731	0.638	.008	14	view →
ESCA	OS	Median	All	0.682	1.000	.029	12	view →
UVM	OS	Quartile	III,IV	0.234	1.000	.028	7	view →
KIRP	DFS	Median	All	0.973	0.816	.019	6	view →
ACC	DFS	Median	IV	0.467	0.094	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02691–BLCA (DFS)

Open the BLCA breakdown →